Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
Plus de filtres










Gamme d'année
1.
JAMA Surg ; 152(8)Aug. 2017.
Article de Anglais | BIGG - guides GRADE | ID: biblio-948342

RÉSUMÉ

IMPORTANCE: The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies. OBJECTIVE: To provide new and updated evidence-based recommendations for the prevention of SSI. EVIDENCE REVIEW: A targeted systematic review of the literature was conducted in MEDLINE, EMBASE, CINAHL, and the Cochrane Library from 1998 through April 2014. A modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence and the strength of the resulting recommendation and to provide explicit links between them. Of 5759 titles and abstracts screened, 896 underwent full-text review by 2 independent reviewers. After exclusions, 170 studies were extracted into evidence tables, appraised, and synthesized. FINDINGS: Before surgery, patients should shower or bathe (full body) with soap (antimicrobial or nonantimicrobial) or an antiseptic agent on at least the night before the operative day. Antimicrobial prophylaxis should be administered only when indicated based on published clinical practice guidelines and timed such that a bactericidal concentration of the agents is established in the serum and tissues when the incision is made. In cesarean section procedures, antimicrobial prophylaxis should be administered before skin incision. Skin preparation in the operating room should be performed using an alcohol-based agent unless contraindicated. For clean and clean-contaminated procedures, additional prophylactic antimicrobial agent doses should not be administered after the surgical incision is closed in the operating room, even in the presence of a drain. Topical antimicrobial agents should not be applied to the surgical incision. During surgery, glycemic control should be implemented using blood glucose target levels less than 200 mg/dL, and normothermia should be maintained in all patients. Increased fraction of inspired oxygen should be administered during surgery and after extubation in the immediate postoperative period for patients with normal pulmonary function undergoing general anesthesia with endotracheal intubation. Transfusion of blood products should not be withheld from surgical patients as a means to prevent SSI. CONCLUSIONS AND RELEVANCE: This guideline is intended to provide new and updated evidence-based recommendations for the prevention of SSI and should be incorporated into comprehensive surgical quality improvement programs to improve patient safety.


Sujet(s)
Humains , Soins postopératoires/méthodes , Infection de plaie opératoire/prévention et contrôle , Asepsie , Antibioprophylaxie/méthodes , Immunosuppresseurs/administration et posologie , Injections articulaires , Anticoagulants/administration et posologie , Noxas/administration et posologie
2.
Chem Biol Interact ; 206(3): 462-71, 2013 Dec 05.
Article de Anglais | MEDLINE | ID: mdl-23994502

RÉSUMÉ

The cation channel TRPA1 functions as a chemosensory protein and is directly activated by a number of noxious inhalants. A pulmonary expression of TRPA1 has been described in sensory nerve endings and its stimulation leads to the acceleration of inflammatory responses in the lung. Whereas the function of TRPA1 in neuronal cells is well defined, only few reports exist suggesting a role in epithelial cells. The aim of the present study was therefore (1) to evaluate the expression of TRPA1 in pulmonary epithelial cell lines, (2) to characterize TRPA1-promoted signaling in these cells, and (3) to study the extra-neuronal expression of this channel in lung tissue sections. Our results revealed that the widely used alveolar type II cell line A549 expresses TRPA1 at the mRNA and protein level. Furthermore, stimulating A549 cells with known TRPA1 activators (i.e., allyl isothiocyanate) led to an increase in intracellular calcium levels, which was sensitive to the TRPA1 blocker ruthenium red. Investigating TRPA1 coupled downstream signaling cascades it was found that TRPA1 activation elicited a stimulation of ERK1/2 whereas other MAP kinases were not affected. Finally, using epithelial as well as neuronal markers in immunohistochemical approaches, a non-neuronal TRPA1 protein expression was detected in distal parts of the porcine lung epithelium, which was also found examining human lung sections. TRPA1-positive staining co-localized with both epithelial and neuronal markers underlining the observed epithelial expression pattern. Our findings of a functional expression of TRPA1 in pulmonary epithelial cells provide causal evidence for a non-neuronal TRPA1-mediated control of inflammatory responses elicited upon TRPA1-mediated registration of toxic inhalants in vivo.


Sujet(s)
Pneumocytes/effets des médicaments et des substances chimiques , Pneumocytes/métabolisme , Canaux calciques/génétique , Canaux calciques/métabolisme , Protéines de tissu nerveux/génétique , Protéines de tissu nerveux/métabolisme , Noxas/toxicité , Canaux cationiques TRP/génétique , Canaux cationiques TRP/métabolisme , Lésion pulmonaire aigüe/induit chimiquement , Lésion pulmonaire aigüe/métabolisme , Animaux , Signalisation calcique/effets des médicaments et des substances chimiques , Lignée cellulaire , Expression des gènes , Humains , Isothiocyanates/pharmacologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Protéines de tissu nerveux/agonistes , Noxas/administration et posologie , ARN messager/génétique , ARN messager/métabolisme , Suidae , Membre-1 de la sous-famille A de canaux cationiques à potentiel de récepteur transitoire , Canaux cationiques TRP/agonistes
3.
Med Clin (Barc) ; 138(3): 127-32, 2012 Feb 18.
Article de Espagnol | MEDLINE | ID: mdl-21453940

RÉSUMÉ

We discuss different interpretations of the term poison as well as the need of bringing up to date the changes in this matter according to the science progress. A clear and exact definition is proposed after analysing the factors that affect the relativity of the concept and its boundaries. The proposal for a definition is presented taking into account the most broadly extended concepts concerning its significance. That is to say: "a poison is, for human beings and their non-pathogenic and non-harmful biological environment, an electromagnetic or corpuscular radiation, or a non-infectious chemical agent, structured no larger in size than a small particle or fibre that, after being generated internally or after contact, penetration and/or absorption by a live organism, in sufficiently high dose, can produce or produces a direct or indirect adverse effect unrelated to its temperature or measurable electrical potential difference". The scientific knowledge needs accurate definitions to avoid ambiguities.


Sujet(s)
Toxiques , Terminologie comme sujet , Toxicologie , Relation dose-effet des médicaments , Humains , Noxas/administration et posologie , Noxas/pharmacocinétique , Noxas/toxicité , Toxiques/administration et posologie , Toxiques/pharmacocinétique , Toxiques/toxicité
4.
Otolaryngol Head Neck Surg ; 143(6): 837-42, 2010 Dec.
Article de Anglais | MEDLINE | ID: mdl-21109087

RÉSUMÉ

OBJECTIVE: It is not known how many olfactory receptor neurons should be intact to maintain olfaction in mouse models treated with 3-methylindole. The aim of this study is to investigate the relationship between a simple olfactory test outcome and the olfactory neuronal population. STUDY DESIGN: Mouse model. SETTING: Animal laboratory of the Seoul National University Bundang Hospital. SUBJECTS AND METHODS: Olfactory dysfunction was induced by intraperitoneal injection of 3-methylindole in 38 six-week-old female C57BL6 mice. Olfactory function was evaluated by a food-finding test following 72-hour starvation. The olfactory neuronal population was quantified by olfactory marker protein (OMP) expression. RESULTS: The average time for finding food was 8.1 seconds in control mice. It was 13.4, 84.4, 90.1, and 111.4 seconds for mice injected with 100, 200, 300, and 400 µg/g of 3-methylindole, respectively. Harvesting the whole olfactory neuroepithelium, densitometric analysis showed significant decrease of OMP in the 300- and 400-µg/g groups as compared with controls (18.8% and 17.5% of relative density, respectively). In the olfactory bulb, there was a significant decrease of OMP in the 200-, 300-, and 400-µg/g groups (44.5%, 37.0%, and 9.0% of relative density, respectively). The food-finding time had a significant reverse correlation with the relative density of OMP both in the olfactory bulb and in the olfactory neuroepithelium. CONCLUSION: Our study showed that olfactory impairment was correlated with olfactory neuronal population in mice treated with 3-methylindole. The food-finding test would be a useful tool that could be easily performed without special training in the 3-methylindole-treated C57BL6 anosmic mouse model.


Sujet(s)
Noxas/effets indésirables , Troubles de l'olfaction/induit chimiquement , Neurorécepteurs olfactifs/effets des médicaments et des substances chimiques , 3-Methylindole/effets indésirables , Odorat/effets des médicaments et des substances chimiques , Animaux , Modèles animaux de maladie humaine , Femelle , Injections péritoneales , Souris , Souris de lignée C57BL , Noxas/administration et posologie , Protéine marqueur olfactif/biosynthèse , 3-Methylindole/administration et posologie
5.
Toxicol Pathol ; 36(6): 818-26, 2008 Oct.
Article de Anglais | MEDLINE | ID: mdl-18776161

RÉSUMÉ

Urinary metabolic fingerprinting with Fourier transform-ion cyclotron resonance mass spectrometry (FT-ICR MS) was performed to monitor metabolic changes in an alpha-naphthylisothiocyanate (ANIT)-induced rat model of intrahepatic cholestasis and to investigate the relationships among metabolic changes, histopathology, and blood chemistry. ANIT was administered orally as a single dose of 100 mg/kg. Urine samples were collected predose (-31 to -24 hours) and postdose at 0-7, 7-24, 24-31, 31-48, 48-55, 55-72, and 72-96 hours, and serum samples were collected on days 1, 2, and 4 postdose. Increased levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and total bilirubin were seen on day 2. The negative ion profiles for urine samples collected after 7-24, 24-31, 31-48, and 48-55 hours differed from the predose profile based on principal component analysis. Onset of recovery was observed after 24-31 hours, when the urinary composition reverted toward the predose position. In conclusion, it is possible to monitor the progression of and recovery from drug-induced hepatotoxicity by urinary metabolic fingerprinting with FT-ICR MS and to search for potential biomarkers involved in intrahepatic cholestasis.


Sujet(s)
1-Naphtyl-isothiocyanate/toxicité , Marqueurs biologiques/urine , Cholestase intrahépatique/induit chimiquement , 1-Naphtyl-isothiocyanate/administration et posologie , Alanine transaminase/sang , Phosphatase alcaline/sang , Animaux , Aspartate aminotransferases/sang , Bilirubine/sang , Marqueurs biologiques/composition chimique , Cholestase intrahépatique/sang , Cholestase intrahépatique/anatomopathologie , Cholestase intrahépatique/urine , Cyclotrons , Analyse de Fourier , Foie/anatomopathologie , Mâle , Spectrométrie de masse , Noxas/administration et posologie , Noxas/toxicité , Analyse en composantes principales , Rats
6.
Brain Res Bull ; 76(1-2): 57-62, 2008 May 15.
Article de Anglais | MEDLINE | ID: mdl-18395611

RÉSUMÉ

Iron is a commonly used metal to induce neuronal hyperactivity and oxidative stress. Iron levels rise in the brain in some neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. A body of evidence indicates a link between neuronal death and nitric oxide. The present study was performed to investigate whether nitric oxide produced by inducible nitric oxide synthase is involved in iron-induced neuron death. For this purpose rats were divided into four groups: control, iron, aminoguanidine and iron+aminoguanidine. Animals in iron and iron+aminoguanidine groups received intracerebroventricular FeCl3 injection (200 mM, 2.5 microl). Rats belonging to control and aminoguanidine groups received the same amount of saline into the cerebral ventricles. All animals were kept alive for 10 days following the operation and animals in aminoguanidine and iron+aminoguanidine groups received intraperitoneal aminoguanidine injections once a day (100mg/kg day) during this period. After 10 days, rats were perfused intracardially under deep urethane anesthesia. Removed brains were processed using the standard histological techniques. The total numbers of neurons in hippocampus of all rats were estimated with the unbiased stereological techniques. It was found that aminoguanidine decreased mean neuron loss from 43.4% to 20.3%. Results of the present study suggest that aminoguanidine may attenuate the neurotoxic effects of iron by inhibiting inducible nitric oxide synthase.


Sujet(s)
Antienzymes/métabolisme , Composés du fer III/toxicité , Guanidines/métabolisme , Neuroprotecteurs/métabolisme , Noxas/toxicité , Animaux , Chlorures , Composés du fer III/administration et posologie , Hippocampe/cytologie , Mâle , Neurones/cytologie , Neurones/métabolisme , Syndromes neurotoxiques , Monoxyde d'azote/métabolisme , Nitric oxide synthase type II/antagonistes et inhibiteurs , Nitric oxide synthase type II/métabolisme , Noxas/administration et posologie , Rats , Rat Wistar
7.
J Environ Health ; 69(6): 24-6, 46; quiz 50, 2007.
Article de Anglais | MEDLINE | ID: mdl-17265727

RÉSUMÉ

Methyl bromide (MB), an agricultural fumigant used in the United States, is capable of reducing or eliminating Bacillis anthracis spores. In the event of a bioterrorist attack, MB might serve as an excellent decontaminating agent because it leaves no residue and does not damage furnishings and commodities.


Sujet(s)
Bacillus anthracis/effets des médicaments et des substances chimiques , Fumigation , Hydrocarbures bromés/immunologie , Noxas/immunologie , Bacillus anthracis/immunologie , Formation continue , Humains , Hydrocarbures bromés/administration et posologie , Noxas/administration et posologie , États-Unis
8.
J Pediatr Surg ; 40(1): 22-5, 2005 Jan.
Article de Anglais | MEDLINE | ID: mdl-15868553

RÉSUMÉ

BACKGROUND/PURPOSE: This study was aimed at determining whether intraoperative intratracheal pulmonary ventilation (ITPV) could prevent/treat respiratory complications of laparoscopy in a model of pediatric pulmonary insufficiency. METHODS: Severe lung injury was induced in 0- to 2-month-old lambs (n = 5) by endotracheal saline lavage. Animals then underwent establishment of CO2 pneumoperitoneum. Intraperitoneal pressures were progressively raised from 0 to 15 mm Hg, at intervals of 5 mm Hg. At each interval, blood gas and hemodynamic data were recorded, 20 minutes after initiation of both conventional ventilation and pure ITPV. All ventilatory parameters were constant and identical on both modes of ventilation. RESULTS: On conventional ventilation, severe respiratory acidosis and hypoxemia ensued at intraperitoneal pressures of 5 mm Hg and 10 mm Hg or more, respectively. Compared with conventional ventilation, ITPV led to statistically significant decreases in PCO2 at intraperitoneal pressures of 5 mm Hg (43.2 +/- 5.2 vs 56.1 +/- 6.6 mm Hg) and 10 mm Hg (45.1 +/- 3.2 vs 61 +/- 6.3 mm Hg) and to significant increases in PO2 at 10 mm Hg (92 +/- 10.2 vs 61 +/- 8.1 mm Hg), resolving the acidosis and hypoxemia at those pressure levels. CONCLUSIONS: Compared with conventional ventilation, ITPV improves both CO2 removal and oxygenation during CO2 pneumoperitoneum in a pediatric lung injury model. Intratracheal pulmonary ventilation may be a safer intraoperative mode of ventilation for neonates and children with respiratory failure who require laparoscopy.


Sujet(s)
Laparoscopie/effets indésirables , Pneumopéritoine/complications , Ventilation artificielle/méthodes , Insuffisance respiratoire/thérapie , Acidose respiratoire/étiologie , Administration par inhalation , Animaux , Dioxyde de carbone/usage thérapeutique , Modèles animaux de maladie humaine , Gaz/usage thérapeutique , Période peropératoire , Laparoscopie/méthodes , Noxas/administration et posologie , Pression/effets indésirables , Échanges gazeux pulmonaires , /induit chimiquement , Insuffisance respiratoire/étiologie , Ovis , Chlorure de sodium/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...